相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Triple-negative breast cancer: Novel therapies and new directions
Sumanta Kumar Pal et al.
MATURITAS (2009)
Clinical Utility of Microarrays: Current Status, Existing Challenges and Future Outlook
Xinmin Li et al.
CURRENT GENOMICS (2008)
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
J. Devon Roll et al.
MOLECULAR CANCER (2008)
Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
Nancy Dumont et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Epidemiology of basal-like breast cancer
Robert C. Millikan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
Epigenetic regulation as a new target for breast cancer therapy
Vered Stearns et al.
CANCER INVESTIGATION (2007)
Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
Maureen Cronin et al.
CLINICAL CHEMISTRY (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
Anne Vincent-Salomon et al.
BREAST CANCER RESEARCH (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
Molecular subtypes of breast cancer and amplification of topoisomerase IIα:: predictive role in dose intensive adjuvant chemotherapy
J. Hannemann et al.
BRITISH JOURNAL OF CANCER (2006)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi et al.
GENES CHROMOSOMES & CANCER (2006)
A genetic signature can predict prognosis and response to therapy in breast cancer:: Onco type DX
Virginia Kaklamani
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Converting a breast cancer microarray signature into a high-throughput diagnostic test
Annuska M. Glas et al.
BMC GENOMICS (2006)
Discovery and validation of breast cancer subtypes
Amy V. Kapp et al.
BMC GENOMICS (2006)
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes
Mi-Jung Kim et al.
HUMAN PATHOLOGY (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Basoluminal carcinoma:: A new biologically and prognostically distinct entity between basal and luminal breast cancer
Mervi Laakso et al.
CLINICAL CANCER RESEARCH (2006)
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
S. Banerjee et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast
L. G. Fulford et al.
HISTOPATHOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
Therese Sorlie et al.
BMC GENOMICS (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation
EA Rakha et al.
JOURNAL OF PATHOLOGY (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
Adjuvant trastuzumab: A milestone in the treatment of HER-2-positive early breast cancer
Jose Baselga et al.
ONCOLOGIST (2006)
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Stefano Calza et al.
BREAST CANCER RESEARCH (2006)
Typical medullary breast carcinomas have a basal/myoepithelial phenotype
J Jacquemier et al.
JOURNAL OF PATHOLOGY (2005)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer
YX Wang et al.
LANCET (2005)
Prognostic relevance of basal cytokeratin expression in operable breast cancer
P Potemski et al.
ONCOLOGY (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression predictors of breast cancer outcomes
E Huang et al.
LANCET (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer
C Sotiriou et al.
BREAST CANCER RESEARCH (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation
C Jones et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases
H Tsuda et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
